Resetting the epigenetic balance for cancer therapy
from Feinberg School of Medicine
Cancer
A ‘dirty bomb’ battles cancer metastasis
Enzyme blocker stops growth of deadly brain tumor
from Feinberg School of Medicine
Evaluating drug regimens for high-risk prostate cancer
from Feinberg School of Medicine
Top-down approach gets to the bottom of cancer
Genome analysis identifies mutations in pediatric cancers
from Feinberg School of Medicine
Tracking quality of life during prostate cancer treatment
from Feinberg School of Medicine
Evaluating pediatric leukemia treatment
from Feinberg School of Medicine
Nut consumption linked to increased colon cancer survival
from Feinberg School of Medicine
Obesity linked to improved survival in male melanoma patients
from Feinberg School of Medicine
Curated cancer care
from Feinberg School of Medicine
Machines see the future for patients diagnosed with brain tumors
Sensing cancer before it’s too late
New insights into prostate cancer treatment and screening
from Feinberg School of Medicine
Chemotherapy drug shows promise in treating everyday allergies
from Feinberg School of Medicine
Evaluating quality of life after kidney cancer treatments
from Feinberg School of Medicine
Huntington's disease provides new cancer weapon
Rare melanoma shows sensitivity to immune therapy
from Feinberg School of Medicine
Ph.D. student explores role of exosomes in cancer metastasis
from Feinberg School of Medicine
Nanoshells provide new approach to targeted chemotherapy delivery
from Feinberg School of Medicine